Published in J Cataract Refract Surg on March 01, 2006
Osmotic stress, not aldose reductase activity, directly induces growth factors and MAPK signaling changes during sugar cataract formation. Exp Eye Res (2012) 0.92
Differences of bFGF gene expression in lens epithelial cells between fetuses and cataract patients. Int J Ophthalmol (2010) 0.81
MAPK activation in mature cataract associated with Noonan syndrome. BMC Ophthalmol (2013) 0.77
EGFR inhibitor Gefitinib attenuates posterior capsule opacification in vitro and in the ex vivo human capsular bag model. Graefes Arch Clin Exp Ophthalmol (2014) 0.76
Effects of long-acting somatostatin analogues on redox systems in rat lens in experimental diabetes. Int J Exp Pathol (2014) 0.75
EGF receptor inhibitor erlotinib as a potential pharmacological prophylaxis for posterior capsule opacification. Graefes Arch Clin Exp Ophthalmol (2013) 0.75
The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology (2011) 6.33
Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis. Clin Infect Dis (2004) 1.68
Morphometric changes of the choriocapillaris and the choroidal vasculature in eyes with advanced glaucomatous changes. Vision Res (2002) 1.27
Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver. Prog Histochem Cytochem (2007) 1.18
A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration. Acta Ophthalmol (2014) 1.15
[Ophthalmia nodosa caused by the hairs of the bird spider (family Theraphosidae) or hairy megalomorph (known in the US as tarantula)--case report and review of the literature]. Klin Monbl Augenheilkd (2003) 1.02
Phenotypic variability in three carriers from a family with choroideremia and a frameshift mutation 1388delCCinsG in the REP-1 gene. Ophthalmic Genet (2003) 0.96
Effect of growth factors on bovine retinal pigment epithelial cell migration and proliferation. Ophthalmic Res (2004) 0.93
[Spontaneous dislocation to the anterior chamber of a lens luxated in the vitreous body: two cases]. Klin Monbl Augenheilkd (2003) 0.91
Long term effects of lutein, zeaxanthin and omega-3-LCPUFAs supplementation on optical density of macular pigment in AMD patients: the LUTEGA study. Graefes Arch Clin Exp Ophthalmol (2013) 0.91
Tetraspanin CD9 is involved in the migration of retinal microvascular endothelial cells. Int J Mol Med (2007) 0.89
[Ultrasound biomicroscopy in eyelid lesions - a clinical study on 30 patients]. Klin Monbl Augenheilkd (2002) 0.88
VEGF but not PlGF disturbs the barrier of retinal endothelial cells. Exp Eye Res (2013) 0.88
TGFbeta induces transdifferentiation of iBREC to alphaSMA-expressing cells. Int J Mol Med (2006) 0.86
Angiotensin blockade to reduce microvascular damage in diabetes mellitus. Dtsch Arztebl Int (2009) 0.86
Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences. Br J Ophthalmol (2012) 0.85
Inhibition of vascular endothelial growth factor (VEGF) is sufficient to completely restore barrier malfunction induced by growth factors in microvascular retinal endothelial cells. Br J Ophthalmol (2011) 0.84
Inhibition of protein kinase C is not sufficient to prevent or reverse effects of VEGF165 on claudin-1 and permeability in microvascular retinal endothelial cells. Invest Ophthalmol Vis Sci (2009) 0.83
Generation and characterization of iBREC: novel hTERT-immortalized bovine retinal endothelial cells. Int J Mol Med (2005) 0.82
[Optical coherence tomography versus ultrasound biomicroscopy of conjunctival and eyelid lesions]. Klin Monbl Augenheilkd (2003) 0.82
The RL-ET-14 cell line mediates expression of glutamine synthetase through the upstream enhancer/promoter region. J Hepatol (2005) 0.81
Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells. Graefes Arch Clin Exp Ophthalmol (2013) 0.80
Octreotide inhibits growth factor-induced bovine choriocapillary endothelial cells in vitro. Graefes Arch Clin Exp Ophthalmol (2002) 0.79
[Recurrent corneal ulcer in a patient with Crohn's disease associated with epidermolysis bullosa acquisita]. Klin Monbl Augenheilkd (2003) 0.79
Posterior fibrous pseudometaplasia of lens epithelial cells in phacic eyes filled with silicone oil. Graefes Arch Clin Exp Ophthalmol (2002) 0.77
Effect of extracellular matrix on proliferation and differentiation of porcine lens epithelial cells. Graefes Arch Clin Exp Ophthalmol (2005) 0.77
The Protein Kinase C Inhibitor: Ruboxistaurin. Dev Ophthalmol (2015) 0.77
Adherence and viability of porcine lens epithelial cells on three different IOL materials in vitro. Graefes Arch Clin Exp Ophthalmol (2003) 0.77
[Ultrasound biomicroscopy of conjunctival lesions]. Klin Monbl Augenheilkd (2003) 0.77
Octreotide inhibits growth factor-induced and basal proliferation of lens epithelial cells in vitro. J Cataract Refract Surg (2005) 0.77
[Evulsion of the optic nerve following blunt bulbar trauma. Case report and review of the literature]. Klin Monbl Augenheilkd (2003) 0.77
[Primary lipid keratopathy]. Klin Monbl Augenheilkd (2002) 0.76
[Lamellar kreatoplasty - new concepts]. Klin Monbl Augenheilkd (2004) 0.75
[Highlights from today's Klinische Monatsblätter für Augenheilkunde]. Klin Monbl Augenheilkd (2013) 0.75
Binding of VEGF-A is sufficient to abrogate the disturbing effects of VEGF-B together with VEGF-A on retinal endothelial cells. Graefes Arch Clin Exp Ophthalmol (2015) 0.75
[Steroid therapy of oedematous and neovascular eye diseases]. Klin Monbl Augenheilkd (2003) 0.75
[Diffuse diabetic macular edema - a therapeutic challenge]. Klin Monbl Augenheilkd (2004) 0.75
Inhibition of Single Routes of Intracellular Signaling is Not Sufficient to Neutralize the Biphasic Disturbance of a Retinal Endothelial Cell Barrier Induced by VEGF-A165. Cell Physiol Biochem (2017) 0.75
[Highlights on today's new possibilities of digital photo documentation in clinical practice for ophthalmologists]. Klin Monbl Augenheilkd (2013) 0.75
[Bilateral necrobiotic xanthogranuloma of the eyelids with associated paraproteinemia: Case report and review of literature]. Klin Monbl Augenheilkd (2002) 0.75
[Manufacture of diamond blades via microsystem technology]. Klin Monbl Augenheilkd (2003) 0.75
[A picture is worth a thousand words! A movie tells the whole story!]. Klin Monbl Augenheilkd (2014) 0.75
[Highlights from yesterday's Clinical Monatsblätter of Ophthalmology]. Klin Monbl Augenheilkd (2013) 0.75
[Successful treatment of a periocular lymphoma with radiotherapy]. Klin Monbl Augenheilkd (2003) 0.75
[Treatment of choroidal neovascularisations with photodynamic therapy]. Klin Monbl Augenheilkd (2003) 0.75
["Hot Topic"]. Klin Monbl Augenheilkd (2016) 0.75
[Enterococcal endophthalmitis following cataract surgery]. Klin Monbl Augenheilkd (2002) 0.75
In-the-bag dislocation of a hydrophilic acrylic intraocular lens. J Cataract Refract Surg (2003) 0.75
[40 years of German-speaking ophthalomologists (DOP)]. Klin Monbl Augenheilkd (2012) 0.75
[New developments in the treatment of diabetic macular oedema]. Klin Monbl Augenheilkd (2003) 0.75
[Always looking to the future--read KliMo and publish in KliMo]. Klin Monbl Augenheilkd (2014) 0.75
[100th Congress of the German Society of Ophthalmology 26-9 September 2002]. Klin Monbl Augenheilkd (2003) 0.75
[Editorial for: Lang SJ, Wenzel M, Böhringer D, Reinhard T. Systematic Analysis of the Annual Quality Reports of the Federal Joint Committee with Regard to Cataract Surgery]. Klin Monbl Augenheilkd (2014) 0.75
["There is nothing more constant than change" - Heraclitus 535 BC]. Klin Monbl Augenheilkd (2016) 0.75
[The Ocularpathologist in Everday Clinical Routine]. Klin Monbl Augenheilkd (2015) 0.75